Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.
Yadav S, Gupta SP, Srivastava G, Srivastava PK, Singh MP.
Neurochem Res. 2012 Apr;37(4):875-84. Epub 2011 Dec 27.
Related citations
Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson's disease.
Thenral ST, Vanisree AJ.
Neurochem Res. 2012 Mar;37(3):512-5. Epub 2011 Nov 15.
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method.
Ohrfelt A, Zetterberg H, Andersson K, Persson R, Secic D, Brinkmalm G, Wallin A, Mulugeta E, Francis PT, Vanmechelen E, Aarsland D, Ballard C, Blennow K, Westman-Brinkmalm A.
Neurochem Res. 2011 Nov;36(11):2029-42. Epub 2011 Jun 16.
Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.
Venkateshappa C, Harish G, Mythri RB, Mahadevan A, Bharath MM, Shankar SK.
Neurochem Res. 2012 Feb;37(2):358-69. Epub 2011 Oct 5.
Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
Kabuto H, Yamanushi TT.
Neurochem Res. 2011 Dec;36(12):2244-9. Epub 2011 Jul 19.
Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.
Martínez-Hernández R, Montes S, Higuera-Calleja J, Yescas P, Boll MC, Diaz-Ruiz A, Rios C.
Neurochem Res. 2011 Nov;36(11):2111-5. Epub 2011 Jun 26.
Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.
Wu G, Huang J, Feng X, Zhang A, Li J, Pang S, Gu K, Dong H, Zhang J, Gao H, Yan B.
Neurochem Res. 2011 Oct;36(10):1939-44. Epub 2011 Jun 5.
Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease.
Kaur H, Chauhan S, Sandhir R.
Neurochem Res. 2011 Aug;36(8):1435-43. Epub 2011 Apr 12.
Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.
Mythri RB, Venkateshappa C, Harish G, Mahadevan A, Muthane UB, Yasha TC, Srinivas Bharath MM, Shankar SK.
Neurochem Res. 2011 Aug;36(8):1452-63. Epub 2011 Apr 12.
GluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian rat.
Ba M, Kong M, Yu G, Sun X, Liu Z, Wang X.
Neurochem Res. 2011 Jun;36(6):1135-44. Epub 2011 Apr 3.
Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: implications in Parkinson's disease.
Ortega-Arellano HF, Jimenez-Del-Rio M, Velez-Pardo C.
Neurochem Res. 2011 Jun;36(6):1073-86. Epub 2011 Mar 26.
Assessment of the efficacy of solutes from extremophiles on protein aggregation in cell models of Huntington's and Parkinson's diseases.
Jorge CD, Ventura R, Maycock C, Outeiro TF, Santos H, Costa J.
Neurochem Res. 2011 Jun;36(6):1005-11. Epub 2011 Mar 17.
Mice lacking major brain gangliosides develop parkinsonism.
Wu G, Lu ZH, Kulkarni N, Amin R, Ledeen RW.
Neurochem Res. 2011 Sep;36(9):1706-14. Epub 2011 Mar 12.
Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.
Cordellini MF, Piazzetta G, Pinto KC, Delattre AM, Matheussi F, Carolino RO, Szawka RE, Anselmo-Franci JA, Ferraz AC.
Neurochem Res. 2011 Jun;36(6):955-61. Epub 2011 Feb 24.
Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
Yong Y, Ding H, Fan Z, Luo J, Ke ZJ.
Neurochem Res. 2011 Mar;36(3):367-74. Epub 2011 Jan 4.
Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency.
Sengupta T, Vinayagam J, Nagashayana N, Gowda B, Jaisankar P, Mohanakumar KP.
Neurochem Res. 2011 Jan;36(1):177-86. Epub 2010 Oct 23.
The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease.
Oses JP, Batassini C, Pochmann D, Böhmer AE, Vuaden FC, Silvestrin RB, Oliveira A, Bonan CD, Bogo MR, Souza DO, Portela LV, Sarkis JJ, Mello e Souza T.
Neurochem Res. 2011 Feb;36(2):215-22. Epub 2010 Nov 4.
Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.
Zheng H, Fridkin M, Youdim MB.
Neurochem Res. 2010 Dec;35(12):2117-23. Epub 2010 Oct 28.
Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells.
Zeevalk GD, Bernard LP, Guilford FT.
Neurochem Res. 2010 Oct;35(10):1575-87. Epub 2010 Jun 10.
Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.
Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.
Neurochem Res. 2010 Oct;35(10):1522-9. Epub 2010 Jul 24.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on